A Phase 2 clinical trial is currently recruiting adults with relapsing types of multiple sclerosis (MS) to investigate Zenas Biopharma’s experimental therapy obexelimab as a weekly subcutaneous ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback